Personalized Multimorbidity Management for Patients with Type 2 Diabetes
  Using Reinforcement Learning of Electronic Health Records
  Comorbid chronic conditions are common among people with type 2 diabetes. We
developed an Artificial Intelligence algorithm, based on Reinforcement Learning
(RL), for personalized diabetes and multi-morbidity management with strong
potential to improve health outcomes relative to current clinical practice. In
this paper, we modeled glycemia, blood pressure and cardiovascular disease
(CVD) risk as health outcomes using a retrospective cohort of 16,665 patients
with type 2 diabetes from New York University Langone Health ambulatory care
electronic health records in 2009 to 2017. We trained a RL prescription
algorithm that recommends a treatment regimen optimizing patients' cumulative
health outcomes using their individual characteristics and medical history at
each encounter. The RL recommendations were evaluated on an independent subset
of patients. The results demonstrate that the proposed personalized
reinforcement learning prescriptive framework for type 2 diabetes yielded high
concordance with clinicians' prescriptions and substantial improvements in
glycemia, blood pressure, cardiovascular disease risk outcomes.
